Intercellular Communication Reveals Therapeutic Potential of Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer.

Liu, Yang; Fang, Yu; Bao, Lili; Wu, Feng; Wang, Shilong; Hao, Siyu

Liu, Yang; Fang, Yu; Bao, Lili; Wu, Feng; Wang, Shilong; Hao, Siyu.

Affiliation

Liu Y; Pharmacy Intravenous Admixture Services, The Second Affiliated Hospital of Harbin Medical University, Harbin 150081, China.
Fang Y; Department of Phase I Clinical Trial Ward, Harbin Medical University Cancer Hospital, Harbin 150081, China.
Bao L; Pharmacy Intravenous Admixture Services, The Second Affiliated Hospital of Harbin Medical University, Harbin 150081, China.
Wu F; Department of Gastroenterology, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, China.
Wang S; Pharmacy Intravenous Admixture Services, The Second Affiliated Hospital of Harbin Medical University, Harbin 150081, China.
Hao S; Department of Dermatology, The Second Affiliated Hospital of Harbin Medical University, Harbin 150081, China.

Biomolecules ; 12(10)2022 Oct 14.

Article de En | MEDLINE | ID: mdl-36291687

Sujet(s)
Mots clés

anti-cancer strategy; cell communication; epithelial-mesenchymal transition; single-cell transcriptomics; triple-negative breast cancer

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Transition épithélio-mésenchymateuse / Tumeurs du sein triple-négatives Type d'étude: Prognostic_studies Limites: Humans Langue: En Journal: Biomolecules Année: 2022 Type de document: Article Pays d'affiliation: Chine Pays de publication: Suisse

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google